Diabetes Drug Maker Hid Test Data on Risks, Files Indicate

The drug giant SmithKline Beecham found in a study as early as 1999 that its diabetes medicine, Avandia, posed risks to the heart, but it never made the information public.

Was it their duty?

If so there will be a great many resources on the surplus market.